These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18824650)

  • 1. Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study".
    Boriani G; Diemberger I; Grigioni F
    Circulation; 2008 Sep; 118(14):e515; author reply e516. PubMed ID: 18824650
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 3. An introduction to the automatic implantable cardioverter-defibrillator and its anesthetic implications.
    Likens ML
    AANA J; 1993 Aug; 61(4):388-93. PubMed ID: 8379287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator and mortality in dialysis patients.
    Saravanan P; Davidson NC
    Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
    [No Abstract]   [Full Text] [Related]  

  • 7. Tincture of time: when to implant a prophylactic cardioverter-defibrillator following coronary revascularization?
    Gillis AM
    J Am Coll Cardiol; 2006 May; 47(9):1818-9. PubMed ID: 16682306
    [No Abstract]   [Full Text] [Related]  

  • 8. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy".
    Madias JE
    Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15900622
    [No Abstract]   [Full Text] [Related]  

  • 9. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy".
    Jachuck M; Satchithananda DK
    Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15897353
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current evidence base for use of the implantable cardioverter-defibrillator.
    Hohnloser SH; Israel CW
    Circulation; 2013 Jul; 128(2):172-83. PubMed ID: 23836830
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):6-7. PubMed ID: 19172139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ
    Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
    Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
    Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy in a woman with an automatic implantable cardioverter-defibrillator. A case report.
    Isaacs JD; Mulholland DH; Hess LW; Allbert JR; Martin RW
    J Reprod Med; 1993 Jun; 38(6):487-8. PubMed ID: 8331632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
    Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.